FLGT vs. CLOV

Last updated Apr 1, 2026

Compare and contrast key facts about Fulgent Genetics, Inc. (FLGT) and Clover Health Investments, Corp. (CLOV).

Performance

FLGT vs. CLOV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fulgent Genetics, Inc. (FLGT) and Clover Health Investments, Corp. (CLOV). The values are adjusted to include any dividend payments, if applicable.

FLGT vs. CLOV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
FLGT Fulgent Genetics, Inc.	-39.47%	42.23%	-36.11%	-2.92%	-70.39%	93.07%	227.06%
CLOV Clover Health Investments, Corp.	-25.11%	-25.40%	230.85%	2.43%	-75.01%	-77.82%	64.41%

Fundamentals

Market Cap FLGT : $489.35M CLOV : $910.34M
EPS FLGT : -$1.97 CLOV : -$0.17
PS Ratio FLGT : 1.52 CLOV : 0.47
PB Ratio FLGT : 0.44 CLOV : 2.95
Total Revenue (TTM) FLGT : $322.67M CLOV : $1.92B
Gross Profit (TTM) FLGT : $130.88M CLOV : $1.99B
EBITDA (TTM) FLGT : -$45.71M CLOV : -$83.86M

Returns By Period

In the year-to-date period, FLGT achieves a -39.47% return, which is significantly lower than CLOV's -25.11% return.

FLGT

• 1D: 1.73%
• 1M: 3.72%
• YTD: -39.47%
• 6M: -29.65%
• 1Y: -5.92%
• 3Y*: -20.14%
• 5Y*: -30.83%
• 10Y*: —

CLOV

• 1D: 2.33%
• 1M: -15.79%
• YTD: -25.11%
• 6M: -42.48%
• 1Y: -50.97%
• 3Y*: 27.70%
• 5Y*: -24.93%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

FLGT vs. CLOV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FLGT

FLGT Risk / Return Rank: 38
FLGT Sharpe Ratio Rank: 37
FLGT Sortino Ratio Rank: 38
FLGT Omega Ratio Rank: 41
FLGT Calmar Ratio Rank: 38
FLGT Martin Ratio Rank: 36

CLOV

CLOV Risk / Return Rank: 9
CLOV Sharpe Ratio Rank: 10
CLOV Sortino Ratio Rank: 10
CLOV Omega Ratio Rank: 12
CLOV Calmar Ratio Rank: 6
CLOV Martin Ratio Rank: 6

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FLGT vs. CLOV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fulgent Genetics, Inc. (FLGT) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FLGT	CLOV	Difference
Sharpe ratio Return per unit of total volatility	-0.10	-0.78	+0.68
Sortino ratio Return per unit of downside risk	0.31	-1.06	+1.37
Omega ratio Gain probability vs. loss probability	1.06	0.87	+0.19
Calmar ratio Return relative to maximum drawdown	-0.12	-0.93	+0.81
Martin ratio Return relative to average drawdown	-0.37	-1.69	+1.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FLGT vs. CLOV - Sharpe Ratio Comparison

The current FLGT Sharpe Ratio is -0.10, which is higher than the CLOV Sharpe Ratio of -0.78. The chart below compares the historical Sharpe Ratios of FLGT and CLOV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	FLGT	CLOV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.10	-0.78	+0.68
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.60	-0.28	-0.32
Sharpe Ratio (All Time) Calculated using the full available price history	0.08	-0.31	+0.38

Correlation

The correlation between FLGT and CLOV is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

FLGT vs. CLOV - Dividend Comparison

Neither FLGT nor CLOV has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

FLGT vs. CLOV - Drawdown Comparison

The maximum FLGT drawdown since its inception was -92.50%, roughly equal to the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for FLGT and CLOV.

Drawdown Indicators

	FLGT	CLOV	Difference
Max Drawdown Largest peak-to-trough decline	-92.50%	-97.19%	+4.69%
Max Drawdown (1Y) Largest decline over 1 year	-55.30%	-54.97%	-0.33%
Max Drawdown (5Y) Largest decline over 5 years	-87.56%	-97.19%	+9.63%
Current Drawdown Current decline from peak	-91.35%	-92.05%	+0.70%
Average Drawdown Average peak-to-trough decline	-61.02%	-76.30%	+15.28%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.10%	30.15%	-12.05%

Volatility

FLGT vs. CLOV - Volatility Comparison

Fulgent Genetics, Inc. (FLGT) and Clover Health Investments, Corp. (CLOV) have volatilities of 11.12% and 11.60%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FLGT	CLOV	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.12%	11.60%	-0.48%
Volatility (6M) Calculated over the trailing 6-month period	56.36%	47.49%	+8.87%
Volatility (1Y) Calculated over the trailing 1-year period	59.62%	65.84%	-6.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	51.89%	89.37%	-37.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	76.13%	86.00%	-9.87%

Financials